YD Bio

YDES · NASDAQ

$4.95+$0.71 (+16.75%)TodayMarket closed ·
Prev close $4.24

About YDES

YD Bio Ltd. is a biotechnology company building an integrated healthcare platform across regulated diagnostics, clinical services, and commercial healthcare markets. The company is headquartered in Taipei City, Taipei. The company went IPO on 2025-08-29. The firm is focused on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of diseases with unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. The company is focused on advancing a diversified portfolio of healthcare solutions across oncology diagnostics, regenerative medicine and clinical trial support. The company is a supplier of clinical trial drugs and has expanded into the development and distribution of post-market auxiliary products. Its core programs include Blood-Based Cancer Detection, Stem Cell- and Exosome-Based Ophthalmology Therapies, and Clinical Trial and AncillaryServices. The company is developing proprietary DNA methylation-based detection technology for a range of cancers, which includes a screening test for the early detection of pancreatic cancer and a monitoring test for recurrent breast cancer.

Employees
5
Headquarters
Taipei City, Taipei
Listed
Aug 29, 2025
Sector
Health Care
Industry
Biotechnology

YDES key statistics

Market cap
408.76M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
369.31K
Volume
105.17K
Open price
$4.28
High today
$5.10
Low today
$4.14
52 Week high
$18.57
52 Week low
$1.70

YD Bio (YDES) at a glance

YD Bio (YDES) last traded at $4.95, with a market cap of 408.76M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $4.14 and $5.10. The current price is 19.7% above the day's low and 2.9% below its high.

Volume so far is 105.17K shares, below the average of 369.31K shares a day.

Over the past year YD Bio has ranged from $1.70 to $18.57, and now sits 19% of the way up that range.

YDES news

  • Avi Kapoor

    Why Webuy Global Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

  • Avi Kapoor

    Why INLIF Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket

  • 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • 12 Health Care Stocks Moving In Tuesday's Intraday Session

  • Avi Kapoor

    Micron, Endeavour Silver, First Majestic Silver, Applied Digital And Other Big Stocks Moving Higher On Friday

  • Avi Kapoor

    Concentrix Posts Downbeat Earnings, Joins Legacy Education, Kingsoft Cloud And Other Big Stocks Moving Lower In Friday's Pre-Market Session

  • Press releasePRNewswire

    YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market

Similar companies

Companies in the same industry as YD Bio

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.